u*1
2 楼
贵州织金山隔乡，
民贫无力造校房。
儿童向学盼得帮。
家乐新舍缘热肠，
梯山为屏林为障。
设施渐备书声郎，
慷慨善举大家赏。
民贫无力造校房。
儿童向学盼得帮。
家乐新舍缘热肠，
梯山为屏林为障。
设施渐备书声郎，
慷慨善举大家赏。
g*j
3 楼
This is a RNAi based technology. As far as I understand, it only recently
started phase I clinical trial, which is a test for toxicity. In other
words, its efficacy and safety have not been proven yet. To put things in
perspective, most drugs entering Phase I clinical trial will fail to pass
all three stages of trials and become commercially available. I know it
sounds very promising, but so does every drug entering phase I trial.
started phase I clinical trial, which is a test for toxicity. In other
words, its efficacy and safety have not been proven yet. To put things in
perspective, most drugs entering Phase I clinical trial will fail to pass
all three stages of trials and become commercially available. I know it
sounds very promising, but so does every drug entering phase I trial.
h*r
4 楼
赞美～
相关阅读